RNS Number : 7626P
Hawkwing PLC
13 February 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR"), AND IS DISCLOSED IN ACCORDANCE WITH THE COMPANY'S OBLIGATIONS UNDER ARTICLE 17 OF MAR

 

13 FEBRUARY 2023

 

 

 

Hawkwing plc (in administration)

 

(the "Company")

 

Appointment of Joint Administrators

 

The Company previously announced that Hanover Investors Management LLP on behalf of Hanover Catalyst Fund ("Hanover") had issued an application seeking to appoint administrators to the Company (the "Administration Application").

 

On 10 February 2023 the Insolvency and Companies Court of the Chancery Division of the High Court of Justice heard the Administration Application. The Court ordered (amongst other things) that Sarah Megan Rayment (Insolvency Practitioner Number: 9162) and Robert John Armstrong (Insolvency Practitioner Number: 21332), each of Kroll Advisory Limited at The Shard, 32 London Bridge St, London SE1 9SG, be appointed as joint administrators of the Company (the "Joint Administrators").

 

The appointment of the Joint Administrators took effect from 4.35pm on 10 February 2023.

The Joint Administrators' contact details are as follows:

            Kroll Advisory Limited
The Shard
32 London Bridge St
London
SE1 9SG
Email: Jen.Harrison@kroll.com

The Joint Administrators will make a further update to the market in due course.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPDZGMZDFGGFZM